Medigen Biotechnology Corp Sustainability Reports
Medigen Biotechnology Corp. is a biopharmaceutical company engaged in new drug development, clinical research, molecular diagnostics, and cellular immunotherapy. Its pipeline focuses primarily on innovative therapies and diagnostics for cancers and liver diseases.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG001SH8BG9
5 reports from 2022 to 2025
